These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1357678)

  • 1. Evidence for noradrenergic involvement in mediating the FG 7142 discriminative stimulus.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1992 Sep; 43(1):77-83. PubMed ID: 1357678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse agonist properties of the THBC discriminative stimulus: asymmetrical generalization with FG 7142.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1991 Mar; 38(3):519-25. PubMed ID: 1648746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse agonist properties of the FG 7142 discriminative stimulus.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1991 Jan; 38(1):99-104. PubMed ID: 1850137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of beta-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors.
    Stephens DN; Shearman GT; Kehr W
    Psychopharmacology (Berl); 1984; 83(3):233-9. PubMed ID: 6089245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus control by the anxiogenic beta-carboline FG 7142: generalization to a physiological stressor.
    Leidenheimer NJ; Schechter MD
    Pharmacol Biochem Behav; 1988 Jun; 30(2):351-5. PubMed ID: 3174766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
    Yang XM; Luo ZP; Zhou JH
    J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-way generalization of clonidine to the discriminative stimulus produced by cocaine.
    Wood DM; Lal H; Yaden S; Emmett-Oglesby MW
    Pharmacol Biochem Behav; 1985 Oct; 23(4):529-33. PubMed ID: 2999832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.
    Sanger DJ
    Psychopharmacology (Berl); 1989; 99(1):117-21. PubMed ID: 2571173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM).
    Kirby LG; Rowan GA; Smith RL; Lucki I
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):351-60. PubMed ID: 7862845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice.
    Venault P; Jacquot F; Save E; Sara S; Chapouthier G
    Life Sci; 1993; 52(7):639-45. PubMed ID: 8094225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of xylazine in rat: discriminability and effects of putative alpha-2 adrenoceptor agonists and antagonists.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):521-7. PubMed ID: 2865356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors.
    Nielsen EB; Jepsen SA; Nielsen M; Braestrup C
    Life Sci; 1985 Jan; 36(1):15-23. PubMed ID: 2981379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration.
    La Marca S; Dunn RW
    Life Sci; 1994; 54(10):PL179-84. PubMed ID: 7906377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex stimulus properties of LSD: a drug discrimination study with alpha 2-adrenoceptor agonists and antagonists.
    Marona-Lewicka D; Nichols DE
    Psychopharmacology (Berl); 1995 Aug; 120(4):384-91. PubMed ID: 8539318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effect of phenylephrine.
    Schechter MD
    Arch Int Pharmacodyn Ther; 1991; 309():20-31. PubMed ID: 1679621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative-stimulus effects of morphine in combination with alpha- and beta-noradrenergic agonists and antagonists in rats.
    Hughes CE; Habash T; Dykstra LA; Picker MJ
    Pharmacol Biochem Behav; 1996 Apr; 53(4):979-86. PubMed ID: 8801606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoceptors and dopamine receptors are not involved in the discriminative stimulus effect of the 5-HT1A receptor agonist flesinoxan.
    Ybema CE; Olivier B; Mos J; Tulp MT; Slangen JL
    Eur J Pharmacol; 1994 Apr; 256(2):141-7. PubMed ID: 8050464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty.
    Mason K; Heal DJ; Stanford SC
    Pharmacol Biochem Behav; 1998 Jun; 60(2):321-7. PubMed ID: 9632213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic mediation of tetrahydro-beta-carboline.
    Schechter MD
    Pharmacol Biochem Behav; 1986 May; 24(5):1209-13. PubMed ID: 3725827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of locally applied noradrenergic agents at cerebellar Purkinje neurons: receptor specificity.
    Parfitt KD; Freedman R; Bickford-Wimer PC
    Brain Res; 1988 Oct; 462(2):242-51. PubMed ID: 2847850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.